Swedencare AB (publ) has today gained access to the business of Vetio which was acquired on June 28th 2021. Vetio is the leading Animal Health Contract Development Manufacturing Organization (CDMO) in North America within contract manufacturing and development of dermatology and supplements liquids together with Veterinary Drug development and manufacturing of solid dose and non-sterile liquids. The purchase price amounts to 181.5 million USD (approximately SEK 1 543 million) and consists of a cash amount of 179 million USD (approximately SEK 1 524 million) and an issue in kind of 184 190 shares in Swedencare, representing 2.3 million USD (approximately SEK 19 million), to the selling management.
For more information about the acquired business, please see press release from June 28th 2021 when the acquisition was made publicn as well as a presentation available on the Company homepage www.swedencare.se
This information was distributed by MFN https://www.mfn.se/